NIH-funded research NIH-funded research

How sex hormones like testosterone and estrogen change wound healing and scarring

Official title: Molecular Mechanisms of Hormone-Mediated Sex Differences in Wound Healing

Funded at Brigham and Women's Hospital · NIH-11393563 · Data updated 2026-11-12

This project looks at how testosterone and estrogen change the way wounds heal and form scars so future care can be better matched to men and women.

More Wound research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 17, 2024
Project endJuly 31, 2029
Funding year2025
Award (this year)$442,444
NIH project number5R35GM157032-02
Project IDNIH-11393563 on NIH RePORTER

Who could benefit from this research

Could help

People with chronic or slow-healing wounds, those with hypertrophic scars, or patients taking testosterone or estrogen therapy would be most relevant to this project.

Less likely to help

Patients with simple acute wounds that heal normally or wounds caused by unrelated mechanical issues may not see direct benefit from this work.

What this research studies

From a patient perspective, the team uses new lab and animal models plus human tissue and clinical observations to trace how sex hormones alter immune responses and tissue repair. They have shown testosterone can slow healing and that people taking testosterone may heal worse, and they will map the molecular pathways behind those effects. The work also explores how estradiol (a form of estrogen) might speed repair and reduce scarring. The goal is to find hormone-driven targets that could lead to better treatments or tailored wound care.

Why it matters

Potential benefit: If successful, this work could lead to hormone-informed treatments or care strategies that speed healing and reduce problematic scarring.

How similar studies have gone: Previous animal studies and clinical observations support that testosterone impairs healing and estrogen may help, but the detailed molecular pathways remain largely untested.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: O'brien-Coon, Devin — Brigham and Women's Hospital
  • Study coordinator: O'brien-Coon, Devin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.